Zhenyan Li
Impact in
-
- MicroRNA in disease regulation
-
- Osteoarthritis Treatment and Mechanisms
Papers in
-
- Ubiquitin and proteasome pathways 3
- Surgery 11
- Co-authors
- Huan‐Tian Zhang (17 shared papers)Zhengang Zha (9 shared papers)Jie Yang (6 shared papers)Zhengang Zha (5 shared papers)Zhao Duan (2 shared papers)Wang Tang (3 shared papers)Bing Niu (1 shared paper)Lin Zhou (4 shared papers)
- Journals
- World Neurosurgery (2 papers)Osteoarthritis and Cartilage (2 papers)Arthritis Research & Therapy (2 papers)Advanced Science (2 papers)Heliyon (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Zhenyan Li
50 papers receiving 478 citations
Peers
Comparison fields: 5 of 110
- Cancer Research 64
- Rheumatology 59
- Molecular Medicine 17
- Genetics 36
- Immunology 68
Countries citing papers authored by Zhenyan Li
This map shows the geographic impact of Zhenyan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenyan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenyan Li more than expected).
Fields of papers citing papers by Zhenyan Li
This network shows the impact of papers produced by Zhenyan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenyan Li. The network helps show where Zhenyan Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhenyan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 42 | |
| 2 | 2022 | 35 | |
| 3 | 2020 | 30 | |
| 4 | 2021 | 28 | |
| 5 | 2022 | 27 | |
| 6 | 2021 | 23 | |
| 7 | 2023 | 22 | |
| 8 | Genome-wide DNA methylation and transcriptome changes in Mycobacterium tuberculosis with rifampicin and isoniazid resistance. | 2018 | 21 |
| 9 | 2020 | 20 | |
| 10 | 2020 | 19 | |
| 11 | 2021 | 17 | |
| 12 | 2024 | 16 | |
| 13 | 2019 | 15 | |
| 14 | 2015 | 15 | |
| 15 | 2019 | 13 | |
| 16 | 2013 | 10 | |
| 17 | 2023 | 8 | |
| 18 | ARID1A is a tumor suppressor and inhibits glioma cell proliferation via the PI3K pathway | 2013 | 8 |
| 19 | 2020 | 7 | |
| 20 | 2021 | 7 |
About Zhenyan Li
Zhenyan Li is a scholar working on Molecular Biology, Surgery, Epidemiology, Immunology and Cancer Research, having authored 54 papers that have together received 483 indexed citations. Recurring topics across this work include Meningioma and schwannoma management (5 papers), Pituitary Gland Disorders and Treatments (5 papers), Osteoarthritis Treatment and Mechanisms (5 papers), Tuberculosis Research and Epidemiology (4 papers), Intracranial Aneurysms: Treatment and Complications (3 papers), Mycobacterium research and diagnosis (3 papers), interferon and immune responses (3 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Cancer Research (64 citations), Rheumatology (59 citations), Molecular Medicine (17 citations), Genetics (36 citations) and Immunology (68 citations). Zhenyan Li has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Huan‐Tian Zhang, Zhengang Zha, Jie Yang, Zhengang Zha, Zhao Duan, Wang Tang, Bing Niu, Lin Zhou, Jiao Zhao and Zheng Huang. Their work appears in journals such as World Neurosurgery, Osteoarthritis and Cartilage, Arthritis Research & Therapy, Advanced Science and Heliyon.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.